Hence, we chose to interrogate a number of Burkitt lymphoma cell lines, assessed their CHK1 expression and activity levels (Fig. 1a) and treated them with the selective CHK1 inhibitors (CHKi), PF-477736 or CHIR-124 to assess their susceptibility to and mode of cell death. This evidence concerns the gene CHEK1 and Burkitt lymphoma.